194 related articles for article (PubMed ID: 38226865)
1. Prodrugs as empowering tools in drug discovery and development: recent strategic applications of drug delivery solutions to mitigate challenges associated with lead compounds and drug candidates.
Subbaiah MAM; Rautio J; Meanwell NA
Chem Soc Rev; 2024 Feb; 53(4):2099-2210. PubMed ID: 38226865
[TBL] [Abstract][Full Text] [Related]
2. Prodrugs - an efficient way to breach delivery and targeting barriers.
Huttunen KM; Rautio J
Curr Top Med Chem; 2011; 11(18):2265-87. PubMed ID: 21671868
[TBL] [Abstract][Full Text] [Related]
3. Design strategies in the prodrugs of HIV-1 protease inhibitors to improve the pharmaceutical properties.
Subbaiah MAM; Meanwell NA; Kadow JF
Eur J Med Chem; 2017 Oct; 139():865-883. PubMed ID: 28865281
[TBL] [Abstract][Full Text] [Related]
4. Is prodrug design an approach to increase water solubility?
Sanches BMA; Ferreira EI
Int J Pharm; 2019 Sep; 568():118498. PubMed ID: 31301465
[TBL] [Abstract][Full Text] [Related]
5. Prodrug design to improve pharmacokinetic and drug delivery properties: challenges to the discovery scientists.
Jana S; Mandlekar S; Marathe P
Curr Med Chem; 2010; 17(32):3874-908. PubMed ID: 20858214
[TBL] [Abstract][Full Text] [Related]
6. Chemistry-enabled drug delivery (prodrugs): recent progress and challenges.
Clas SD; Sanchez RI; Nofsinger R
Drug Discov Today; 2014 Jan; 19(1):79-87. PubMed ID: 23993918
[TBL] [Abstract][Full Text] [Related]
7. Prodrugs for Improved Drug Delivery: Lessons Learned from Recently Developed and Marketed Products.
Markovic M; Ben-Shabat S; Dahan A
Pharmaceutics; 2020 Oct; 12(11):. PubMed ID: 33137942
[TBL] [Abstract][Full Text] [Related]
8. The rationality for using prodrug approach in drug discovery programs for new xenobiotics: opportunities and challenges.
Srinivas NR
Eur J Drug Metab Pharmacokinet; 2011 Jun; 36(2):49-59. PubMed ID: 21404122
[TBL] [Abstract][Full Text] [Related]
9. The Prodrug Approach: A Successful Tool for Improving Drug Solubility.
Jornada DH; dos Santos Fernandes GF; Chiba DE; de Melo TR; dos Santos JL; Chung MC
Molecules; 2015 Dec; 21(1):42. PubMed ID: 26729077
[TBL] [Abstract][Full Text] [Related]
10. Prodrug approaches for the development of a long-acting drug delivery systems.
Chien ST; Suydam IT; Woodrow KA
Adv Drug Deliv Rev; 2023 Jul; 198():114860. PubMed ID: 37160248
[TBL] [Abstract][Full Text] [Related]
11. Prodrugs: design and clinical applications.
Rautio J; Kumpulainen H; Heimbach T; Oliyai R; Oh D; Järvinen T; Savolainen J
Nat Rev Drug Discov; 2008 Mar; 7(3):255-70. PubMed ID: 18219308
[TBL] [Abstract][Full Text] [Related]
12. Phosphate moiety in FDA-approved pharmaceutical salts and prodrugs.
Fulmali A; Bharate SS
Drug Dev Res; 2022 Aug; 83(5):1059-1074. PubMed ID: 35656613
[TBL] [Abstract][Full Text] [Related]
13. Design of ester prodrugs to enhance oral absorption of poorly permeable compounds: challenges to the discovery scientist.
Beaumont K; Webster R; Gardner I; Dack K
Curr Drug Metab; 2003 Dec; 4(6):461-85. PubMed ID: 14683475
[TBL] [Abstract][Full Text] [Related]
14. Amorphous Solid Dispersions or Prodrugs: Complementary Strategies to Increase Drug Absorption.
Rumondor ACF; Dhareshwar SS; Kesisoglou F
J Pharm Sci; 2016 Sep; 105(9):2498-2508. PubMed ID: 26886316
[TBL] [Abstract][Full Text] [Related]
15. Prodrugs: a challenge for the drug development.
Zawilska JB; Wojcieszak J; Olejniczak AB
Pharmacol Rep; 2013; 65(1):1-14. PubMed ID: 23563019
[TBL] [Abstract][Full Text] [Related]
16. smProdrugs: A repository of small molecule prodrugs.
Choudhury C; Kumar V; Kumar R
Eur J Med Chem; 2023 Mar; 249():115153. PubMed ID: 36724634
[TBL] [Abstract][Full Text] [Related]
17. Smart design approaches for orally administered lipophilic prodrugs to promote lymphatic transport.
Elz AS; Trevaskis NL; Porter CJH; Bowen JM; Prestidge CA
J Control Release; 2022 Jan; 341():676-701. PubMed ID: 34896450
[TBL] [Abstract][Full Text] [Related]
18. Prodrugs: Some thoughts and current issues.
Stella VJ
J Pharm Sci; 2010 Dec; 99(12):4755-65. PubMed ID: 20821387
[TBL] [Abstract][Full Text] [Related]
19. Lipidic prodrug approach for improved oral drug delivery and therapy.
Markovic M; Ben-Shabat S; Keinan S; Aponick A; Zimmermann EM; Dahan A
Med Res Rev; 2019 Mar; 39(2):579-607. PubMed ID: 30320896
[TBL] [Abstract][Full Text] [Related]
20. Prodrug strategies to overcome poor water solubility.
Stella VJ; Nti-Addae KW
Adv Drug Deliv Rev; 2007 Jul; 59(7):677-94. PubMed ID: 17628203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
